These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 24637698)
1. Stability of generic meropenem solutions for administration by continuous infusion at normal and elevated temperatures. Franceschi L; Cojutti P; Baraldo M; Pea F Ther Drug Monit; 2014 Oct; 36(5):674-6. PubMed ID: 24637698 [TBL] [Abstract][Full Text] [Related]
2. Stability of meropenem in normal saline solution after storage at room temperature. Jaruratanasirikul S; Sriwiriyajan S Southeast Asian J Trop Med Public Health; 2003 Sep; 34(3):627-9. PubMed ID: 15115140 [TBL] [Abstract][Full Text] [Related]
3. Stability of meropenem and doripenem solutions for administration by continuous infusion. Berthoin K; Le Duff CS; Marchand-Brynaert J; Carryn S; Tulkens PM J Antimicrob Chemother; 2010 May; 65(5):1073-5. PubMed ID: 20176578 [No Abstract] [Full Text] [Related]
4. Stability of generic brands of meropenem reconstituted in isotonic saline. Carlier M; Stove V; Verstraete AG; De Waele JJ Minerva Anestesiol; 2015 Mar; 81(3):283-7. PubMed ID: 25220554 [TBL] [Abstract][Full Text] [Related]
5. Stability of meropenem in polyvinyl chloride bags and an elastomeric infusion device. Smith DL; Bauer SM; Nicolau DP Am J Health Syst Pharm; 2004 Aug; 61(16):1682-5. PubMed ID: 15540479 [TBL] [Abstract][Full Text] [Related]
6. Stability of meropenem in intravenous solutions. Patel PR; Cook SE Am J Health Syst Pharm; 1997 Feb; 54(4):412-21. PubMed ID: 9043564 [TBL] [Abstract][Full Text] [Related]
7. Stability and degradation kinetics of meropenem in powder for injection and reconstituted sample. Mendez AS; Dalomo J; Steppe M; Schapoval EE J Pharm Biomed Anal; 2006 Jun; 41(4):1363-6. PubMed ID: 16533586 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic properties and stability of continuous-infusion meropenem in adults with cystic fibrosis. Kuti JL; Nightingale CH; Knauft RF; Nicolau DP Clin Ther; 2004 Apr; 26(4):493-501. PubMed ID: 15189746 [TBL] [Abstract][Full Text] [Related]
9. Stability of doripenem in vitro in representative infusion solutions and infusion bags. Psathas PA; Kuzmission A; Ikeda K; Yasuo S Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795 [TBL] [Abstract][Full Text] [Related]
10. Thermal and alkaline stability of meropenem: degradation products and cytotoxicity. Mendez A; Chagastelles P; Palma E; Nardi N; Schapoval E Int J Pharm; 2008 Feb; 350(1-2):95-102. PubMed ID: 17904314 [TBL] [Abstract][Full Text] [Related]
11. Compatibility of Meropenem with Different Commercial Peritoneal Dialysis Solutions. Wiesholzer M; Winter A; Kussmann M; Zeitlinger M; Pichler P; Burgmann H; Reznicek G; Poeppl W Perit Dial Int; 2017 1-2; 37(1):51-55. PubMed ID: 27605684 [TBL] [Abstract][Full Text] [Related]
12. Prediction of the stability of meropenem in intravenous mixtures. Takasu Y; Yoshida M; Tange M; Asahara K; Uchida T Chem Pharm Bull (Tokyo); 2015; 63(4):248-54. PubMed ID: 25832020 [TBL] [Abstract][Full Text] [Related]
13. Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli. Lorente L; Lorenzo L; Martín MM; Jiménez A; Mora ML Ann Pharmacother; 2006 Feb; 40(2):219-23. PubMed ID: 16449546 [TBL] [Abstract][Full Text] [Related]
14. High-performance liquid chromatographic assay for meropenem in serum. Elkhaïli H; Niedergang S; Pompei D; Linger L; Leveque D; Jehl F J Chromatogr B Biomed Appl; 1996 Nov; 686(1):19-26. PubMed ID: 8953188 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of 2-hydropropyl-beta-cyclodextrin in the stabilization of frozen formulations. Wong J; Kipp JE; Miller RL; Nair LM; Ray GJ Eur J Pharm Sci; 2014 Oct; 62():281-92. PubMed ID: 24932711 [TBL] [Abstract][Full Text] [Related]
16. Bioequivalence, antibacterial activity and therapeutic outcome of a generic meropenem (Mapenem). Leelarasamee A; Rongrungruang Y; Trakulsomboon S; Pongpech P; Thanawattanawanich P; Jithavech P J Med Assoc Thai; 2008 Jul; 91(7):980-8. PubMed ID: 18839835 [TBL] [Abstract][Full Text] [Related]
17. Development and validation of stability-indicating HPLC method for simultaneous determination of meropenem and potassium clavulanate. Zalewski P; Cielecka-Piontek J; Paczkowska M Acta Pol Pharm; 2014; 71(2):255-60. PubMed ID: 25272645 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic drug monitoring of beta-lactam antibiotics - Influence of sample stability on the analysis of piperacillin, meropenem, ceftazidime and flucloxacillin by HPLC-UV. Pinder N; Brenner T; Swoboda S; Weigand MA; Hoppe-Tichy T J Pharm Biomed Anal; 2017 Sep; 143():86-93. PubMed ID: 28578254 [TBL] [Abstract][Full Text] [Related]
19. The stability of a novel carbapenem antibiotic, meropenem (SM-7338), in a solid state formulation for injection. Takeuchi Y; Takebayashi Y; Sunagawa M; Isobe Y; Hamazume Y; Uemura A; Noguchi T Chem Pharm Bull (Tokyo); 1993 Nov; 41(11):1998-2002. PubMed ID: 8293523 [TBL] [Abstract][Full Text] [Related]
20. Stability of Meropenem After Reconstitution for Administration by Prolonged Infusion. Fawaz S; Barton S; Whitney L; Swinden J; Nabhani-Gebara S Hosp Pharm; 2019 Jun; 54(3):190-196. PubMed ID: 31205331 [No Abstract] [Full Text] [Related] [Next] [New Search]